20 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33158816 | Inhibition of G Protein-Coupled Receptor Kinase 2 Promotes Unbiased Downregulation of IGF1 Receptor and Restrains Malignant Cell Growth. | 2021 Jan 15 | 4 |
2 | 33372534 | Paroxetine Attenuates Cardiac Hypertrophy Via Blocking GRK2 and ADRB1 Interaction in Hypertension. | 2021 Jan 5 | 3 |
3 | 33568523 | Paroxetine-mediated GRK2 inhibition is a disease-modifying treatment for osteoarthritis. | 2021 Feb 10 | 1 |
4 | 34259826 | Effect of Paroxetine-Mediated G-Protein Receptor Kinase 2 Inhibition vs Placebo in Patients With Anterior Myocardial Infarction: A Randomized Clinical Trial. | 2021 Oct 1 | 1 |
5 | 34386323 | Targeted inhibition of GRK2 kinase domain by CP-25 to reverse fibroblast-like synoviocytes dysfunction and improve collagen-induced arthritis in rats. | 2021 Jul | 1 |
6 | 35155607 | Paroxetine and Mortality in Heart Failure: A Retrospective Cohort Study. | 2021 | 1 |
7 | 32234810 | A New Paroxetine-Based GRK2 Inhibitor Reduces Internalization of the μ-Opioid Receptor. | 2020 Jun | 1 |
8 | 31506468 | Computational study of paroxetine-like inhibitors reveals new molecular insight to inhibit GRK2 with selectivity over ROCK1. | 2019 Sep 10 | 2 |
9 | 29980659 | Small-Molecule G Protein-Coupled Receptor Kinase Inhibitors Attenuate G Protein-Coupled Receptor Kinase 2-Mediated Desensitization of Vasoconstrictor-Induced Arterial Contractions. | 2018 Sep | 2 |
10 | 30018141 | GRK2 mediates TCR-induced transactivation of CXCR4 and TCR-CXCR4 complex formation that drives PI3Kγ/PREX1 signaling and T cell cytokine secretion. | 2018 Sep 7 | 1 |
11 | 30366961 | S1P1 receptor phosphorylation, internalization, and interaction with Rab proteins: effects of sphingosine 1-phosphate, FTY720-P, phorbol esters, and paroxetine. | 2018 Dec 21 | 1 |
12 | 30463058 | Development of Inflammatory Immune Response-Related Drugs Based on G Protein-Coupled Receptor Kinase 2. | 2018 | 1 |
13 | 27222484 | Hypothesis: Paroxetine, a G Protein-Coupled Receptor Kinase 2 (GRK2) Inhibitor Reduces Morbidity and Mortality in Patients With Heart Failure. | 2017 Jan | 4 |
14 | 28323425 | Structure-Based Design of Highly Selective and Potent G Protein-Coupled Receptor Kinase 2 Inhibitors Based on Paroxetine. | 2017 Apr 13 | 1 |
15 | 28349925 | Paroxetine alleviates T lymphocyte activation and infiltration to joints of collagen-induced arthritis. | 2017 Mar 28 | 1 |
16 | 29070696 | Structural Determinants Influencing the Potency and Selectivity of Indazole-Paroxetine Hybrid G Protein-Coupled Receptor Kinase 2 Inhibitors. | 2017 Dec | 3 |
17 | 27695334 | Effects of paroxetine-mediated inhibition of GRK2 expression on depression and cardiovascular function in patients with myocardial infarction. | 2016 | 5 |
18 | 27999776 | "Freeze, Don't Move": How to Arrest a Suspect in Heart Failure - A Review on Available GRK2 Inhibitors. | 2016 | 1 |
19 | 24220010 | Structural and functional analysis of g protein-coupled receptor kinase inhibition by paroxetine and a rationally designed analog. | 2014 Feb | 5 |
20 | 25340299 | Identification and characterization of amlexanox as a G protein-coupled receptor kinase 5 inhibitor. | 2014 Oct 22 | 1 |